EP1476184A4 - Immunogen adherence and method of making and using same - Google Patents

Immunogen adherence and method of making and using same

Info

Publication number: EP1476184A4
Authority: EP; European Patent Office
Prior art keywords: making; same; immunogen adherence; immunogen; adherence
Prior art date: 2001-12-28
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP01994346A

Other languages

German (de)

French (fr)

Other versions

EP1476184A1 (en

Inventor

Peter Nash

Donald L Robinson

John W Rosevear

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Camas Inc

Original Assignee

Camas Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-12-28

Filing date

2001-12-28

Publication date

2006-01-04

2001-12-28 Application filed by Camas Inc filed Critical Camas Inc

2004-11-17 Publication of EP1476184A1 publication Critical patent/EP1476184A1/en

2006-01-04 Publication of EP1476184A4 publication Critical patent/EP1476184A4/en

Status Withdrawn legal-status Critical Current

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
- C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K16/1232—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia from Escherichia (G)
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
- A23K20/147—Polymeric derivatives, e.g. peptides or proteins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/08—Clostridium, e.g. Clostridium tetani
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
- C07K2317/11—Immunoglobulins specific features characterized by their source of isolation or production isolated from eggs

EP01994346A 2001-12-28 2001-12-28 Immunogen adherence and method of making and using same Withdrawn EP1476184A4 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PCT/US2001/049588 WO2003061693A1 (en)	2001-12-28	2001-12-28	Immunogen adherence and method of making and using same

Publications (2)

Publication Number	Publication Date
EP1476184A1 EP1476184A1 (en)	2004-11-17
EP1476184A4 true EP1476184A4 (en)	2006-01-04

Family

ID=27608951

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP01994346A Withdrawn EP1476184A4 (en)	2001-12-28	2001-12-28	Immunogen adherence and method of making and using same

Country Status (8)

Country	Link
EP (1)	EP1476184A4 (en)
JP (1)	JP2006504393A (en)
KR (1)	KR20040096491A (en)
CN (1)	CN1543355A (en)
AU (1)	AU2002246753B8 (en)
BR (1)	BR0117062A (en)
CA (1)	CA2438698C (en)
WO (1)	WO2003061693A1 (en)

Citations (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0225254A2 (en) *	1985-11-25	1987-06-10	Ghen Corporation	Specific antibody-containing substance from eggs and method of production and use thereof
US4748018A (en) *	1984-02-07	1988-05-31	Stolle Research & Development Corp.	Method of passive immunization of mammals using avian antibody
WO1996030043A1 (en) *	1995-03-24	1996-10-03	Ophidian Pharmaceuticals	Treatment for verotoxin-producing escherichia coli
WO1998014209A1 (en) *	1996-10-02	1998-04-09	Ovimmune, Inc.	Oral administration of chicken yolk antibodies to treat disease
US5741489A (en) *	1996-05-24	1998-04-21	Anitox Corporation	Passively administered antibody that enhances feed conversion efficiency
US5753228A (en) *	1992-08-25	1998-05-19	Arizona Board Of Regents On Behalf Of The University Of Arizona	Method of treating parasitosis by the enteral administration of hyperimmune hen egg yolk antibodies
EP0955061A1 (en) *	1998-03-20	1999-11-10	Medipharm CZ, s.r.o.	Oral product for the prevention and therapy of porcine gastroenteric infections
DE19910159A1 (en) *	1999-02-26	2000-09-14	Rosemarie Heis	Specific IgY egg yolk antibodies, their extraction and their use
US6162441A (en) *	1999-12-15	2000-12-19	Republic Of Korea (Management: Rural Development Administration)	Method for the production of anti-escherichia. coli O157 : H7 antibody
WO2001048018A1 (en) *	1999-12-27	2001-07-05	University Of Manitoba	Genetic vaccines for the production of chicken egg-yolk antibodies against enterotoxigenic escherichia coli and other pathogens

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5725873A (en) *	1996-07-22	1998-03-10	Wisconsin Alumni Research Foundation	Method of improving the growth or the efficiency of feed conversion of an animal and compositions for use therein
US6083500A (en) *	1997-10-06	2000-07-04	University Of Georgia Research Foundation, Inc.	Biological control of food pathogens in livestock

2001
- 2001-12-28 EP EP01994346A patent/EP1476184A4/en not_active Withdrawn
- 2001-12-28 WO PCT/US2001/049588 patent/WO2003061693A1/en active Application Filing
- 2001-12-28 CN CNA018235352A patent/CN1543355A/en active Pending
- 2001-12-28 CA CA2438698A patent/CA2438698C/en not_active Expired - Lifetime
- 2001-12-28 AU AU2002246753A patent/AU2002246753B8/en not_active Expired
- 2001-12-28 BR BR0117062-7A patent/BR0117062A/en not_active Application Discontinuation
- 2001-12-28 KR KR10-2004-7006486A patent/KR20040096491A/en not_active Application Discontinuation
- 2001-12-28 JP JP2003561636A patent/JP2006504393A/en active Pending

Patent Citations (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4748018A (en) *	1984-02-07	1988-05-31	Stolle Research & Development Corp.	Method of passive immunization of mammals using avian antibody
EP0225254A2 (en) *	1985-11-25	1987-06-10	Ghen Corporation	Specific antibody-containing substance from eggs and method of production and use thereof
US5080895A (en) *	1985-11-25	1992-01-14	Ghen Corporation	Specific antibody-containing substance from eggs and method of production and use thereof
US5080895B1 (en) *	1985-11-25	1998-03-10	Ghen Corp	nd method of production and use thereof Specific antibody-containing substance from eggs a
US5753228A (en) *	1992-08-25	1998-05-19	Arizona Board Of Regents On Behalf Of The University Of Arizona	Method of treating parasitosis by the enteral administration of hyperimmune hen egg yolk antibodies
WO1996030043A1 (en) *	1995-03-24	1996-10-03	Ophidian Pharmaceuticals	Treatment for verotoxin-producing escherichia coli
US5741489A (en) *	1996-05-24	1998-04-21	Anitox Corporation	Passively administered antibody that enhances feed conversion efficiency
WO1998014209A1 (en) *	1996-10-02	1998-04-09	Ovimmune, Inc.	Oral administration of chicken yolk antibodies to treat disease
EP0955061A1 (en) *	1998-03-20	1999-11-10	Medipharm CZ, s.r.o.	Oral product for the prevention and therapy of porcine gastroenteric infections
DE19910159A1 (en) *	1999-02-26	2000-09-14	Rosemarie Heis	Specific IgY egg yolk antibodies, their extraction and their use
US6162441A (en) *	1999-12-15	2000-12-19	Republic Of Korea (Management: Rural Development Administration)	Method for the production of anti-escherichia. coli O157 : H7 antibody
WO2001048018A1 (en) *	1999-12-27	2001-07-05	University Of Manitoba	Genetic vaccines for the production of chicken egg-yolk antibodies against enterotoxigenic escherichia coli and other pathogens

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
See also references of WO03061693A1 *
XP009114736 *
XP009114761 *
XP009114762 *
YOKOYAMA H ET AL: "Passive protective effect of chicken egg yolk immunoglobulins against experimental enterotoxigenic Escherichia coli infection in neonatal piglets", INFECTION AND IMMUNITY, AMERICAN SOCIETY FOR MICROBIOLOGY. WASHINGTON, US, vol. 60, no. 3, March 1992 (1992-03-01), pages 998 - 1007, XP002109373, ISSN: 0019-9567 *

Also Published As

Publication number	Publication date
CA2438698C (en)	2013-12-17
EP1476184A1 (en)	2004-11-17
CN1543355A (en)	2004-11-03
JP2006504393A (en)	2006-02-09
AU2002246753B8 (en)	2009-09-24
AU2002246753B2 (en)	2009-05-28
CA2438698A1 (en)	2003-07-31
KR20040096491A (en)	2004-11-16
BR0117062A (en)	2005-12-13
WO2003061693A1 (en)	2003-07-31
AU2002246753A1 (en)	2003-09-02

Legal Events

Date	Code	Title	Description
2004-10-01	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2004-11-17	17P	Request for examination filed	Effective date: 20040617
2004-11-17	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
2004-11-17	AX	Request for extension of the european patent	Extension state: AL LT LV MK RO SI
2005-10-07	REG	Reference to a national code	Ref country code: HK Ref legal event code: DE Ref document number: 1073425 Country of ref document: HK
2006-01-04	A4	Supplementary search report drawn up and despatched	Effective date: 20051118
2006-08-23	17Q	First examination report despatched	Effective date: 20060201
2007-07-04	17Q	First examination report despatched	Effective date: 20060201
2009-11-27	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2009-12-30	18D	Application deemed to be withdrawn	Effective date: 20090701
2013-07-19	REG	Reference to a national code	Ref country code: HK Ref legal event code: WD Ref document number: 1073425 Country of ref document: HK

Publication	Publication Date	Title
AU2002364528A8 (en)	2003-06-23	Bio-implant and method of making the same
IL200255A (en)	2010-12-30	Method of preparing o-desmethyl-venlafaxine
GB0415646D0 (en)	2004-08-18	Waveguide and method of manufacture
HK1065978A1 (en)	2005-03-11	Condrapable hydrophobic nonwoven and method of making same
AU2001261160A1 (en)	2001-11-12	Prosthesis and method of making
PL357927A1 (en)	2003-06-30	Method of obtaining trimethylpropane
PL353633A1 (en)	2002-11-04	Method of obtaining derivatives of 4"-substituted-9-deoxy-9a-aza-9a-homoerythromycin
PL355161A1 (en)	2003-01-13	Method of manufacture
IL160835A0 (en)	2004-08-31	Catheter and method of using same
ZA200306573B (en)	2006-10-25	A vaccine composition and method of using the same
GB2390505B (en)	2005-03-30	Loudspeaker and method of making same
HK1046646A1 (en)	2003-01-24	Preparations and method of producing the same
GB2389602B (en)	2004-12-29	Cover and method of making same
GB2394359B (en)	2005-06-29	Microelctronic device and method of its manufacture
GB0113869D0 (en)	2001-08-01	Plaster composition and method of making the same
EP1476184A4 (en)	2006-01-04	Immunogen adherence and method of making and using same
AU2002337649A8 (en)	2009-07-30	Method of making fgf-12 and kgf-2
PL351128A1 (en)	2003-06-16	Method of obtaining phenoglycine and derivatives thereof
SI1216975T1 (en)	2005-10-31	Coated ceramic parts and method of fabricating same
EP1435953A4 (en)	2005-05-04	Antivesicant compounds and methods of making and using thereof
AU8626801A (en)	2002-04-02	Method of forming complex
PL356317A1 (en)	2003-04-07	Method of obtaining alkanosulphonylpyridines
PL343141A1 (en)	2002-04-22	Novel silylcarbamates and method of obtaining them
GB0114555D0 (en)	2001-08-08	Plaster composition and method of making the same
GB0114504D0 (en)	2001-08-08	Plaster composition and method of making the same